| Table 1. Ten most highly upregulated genes in MCF-7, | |||||
| SKBR-3, SUM-52, and ZR-75-1-wt breast cancer cell lines | |||||
| by cDNA microarray analysis of 1236 transcripts.* | |||||
| ZR75-1-wt: | MCF-7: | ||||
| GeneName | Cytoband | Ratio | GeneName | Cytoband | Ratio |
| MYBL2 | 20q13.1 | 5.7 | H2AFZ | 4q24 | 5.4 |
| FEN1 | 13q33 | 4.9 | MYBL2 | 20q13.1 | 4.9 |
| CDC25B | 20p13 | 4.3 | Topo II | 17q21-q22 | 4.7 |
| NME1 | 17q22 | 3.8 | GATA3 | 10p15 | 4.7 |
| BRF1 | 14q22-q14 | 3.8 | PRKACA | 19p13.1 | 4.6 |
| Topo II | 17q21-q22 | 3.4 | RCH1 | 17q23 | 4.5 |
| RCH1 | 17q23 | 3.3 | OCLN | 5q12-q13 | 3.5 |
| HepG2 | 1p31-p35 | 3.2 | LAMNB2 | 19p13 | 3.3 |
| PAK2 | 3 | GTF3A | 13q12.3-q13.1 | 3.1 | |
| OCLN | 5q12-q13 | 2.9 | TMP21 | 14q24.3 | 3 |
| SUM-52: | SKBR-3: | ||||
| GeneName | Cytoband | Ratio | GeneName | Cytoband | Ratio |
| NERF | 4 | 17.2 | SDC1 | 2p24 | >100 |
| Topo II | 17q21-q22 | 16.4 | PMI | 17p12-q21 | >100 |
| TAK1 | 6q14-q21 | 12.6 | HLA-DQB1 | 6p21 | >100 |
| CAS | 20q13 | 8.1 | Protein Phosphatase 2A ß-subunit | 5q32-q33 | >100 |
| PTPRZ1 | 7q31.3 | 7.5 | CAS | 20q13 | >100 |
| LIG3 | 17q11.2-q12 | 7.1 | MLP | 1p34 | >100 |
| LAP18 | 1p35-36.1 | 6.7 | MYBL2 | 20q13.1 | >100 |
| GFAP | 17q21 | 6.1 | EGF-LIKE GROWTH FACTOR | 5q23 | >100 |
| NDUFB7 | 19p13 | 5.5 | MAD | 2p12-p13 | >100 |
| EST | 5.1 | CDK4 | 12q14 | >100 | |
| *Genes indicated in bold were overexpressed in two or more cell lines. | |||||